MBIO Insider Trading

Net Selling · 180d
Open-Market Buys (180d)
$237
1 insiders
Open-Market Sells (180d)
$241
2 insiders
Net Insider Flow
-$4
open market, 180d
Reporting Insiders
3
3 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

18 shown
DateInsiderRoleActionSharesPriceValue
Jan 2, 2026Fortress Biotech, Inc.10% OwnerGrant(A)278K$0
Dec 30, 2025Jin DavidDirectorBuy(P)247$0.96$237
Dec 30, 2025Chill Adam J.DirectorSell(S)4$0.95$4
Dec 30, 2025Herskowitz NeilDirectorSell(S)247$0.96$237
Sep 29, 2025Fortress Biotech, Inc.10% OwnerGrant(A)59K$0
Apr 24, 2025Litchman Manuel MDPresident, CEO and Interim CFO, DirectorTax withholding(F)27$1.24$33
Mar 31, 2025Fortress Biotech, Inc.10% OwnerGrant(A)68K$0
Jun 27, 2024Fortress Biotech, Inc.10% OwnerGrant(A)575K$0
May 31, 2024Litchman Manuel MDPresident and CEO, DirectorTax withholding(F)1K$0.35$489
Jan 2, 2024Fortress Biotech, Inc.10% OwnerGrant(A)419K$0
Jul 5, 2023Herskowitz NeilDirectorGrant(A)7K$0
Jul 5, 2023Weiss Michael SDirectorGrant(A)7K$0
Jul 5, 2023Rosenwald Lindsay A MDDirectorGrant(A)7K$0
Jul 5, 2023Chill Adam J.DirectorGrant(A)7K$0
Jul 5, 2023Zelefsky Michael JDirectorGrant(A)7K$0
Apr 24, 2023Litchman Manuel MDPresident and CEO, DirectorTax withholding(F)2K$4.21$7K
Apr 24, 2023Litchman Manuel MDPresident and CEO, DirectorGrant(A)5K$0
Apr 24, 2022Litchman Manuel MDPresident and CEO, DirectorTax withholding(F)1K$12.15$15K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).